Urinary Tract Infection

Urinary Tract Infections (UTIs) are common bacterial infections that affect any part of the urinary system, including the kidneys, ureters, bladder, and urethra. Most UTIs involve the lower urinary tract, particularly the bladder (cystitis) and urethra (urethritis). They are more prevalent in women due to shorter urethras and proximity to the anus. Common symptoms include dysuria, frequency, urgency, suprapubic pain, and cloudy or strong-smelling urine. Escherichia coli is the most frequent causative organism. Risk factors include sexual activity, menopause, urinary retention, catheter use, and underlying urological abnormalities. Diagnosis is typically based on clinical presentation and urinalysis, with urine culture confirming the diagnosis and guiding antibiotic selection. Treatment involves targeted antibiotics, with short-course regimens often sufficient for uncomplicated cases. Recurrent UTIs may require further evaluation and prophylactic measures. Prompt treatment prevents complications such as pyelonephritis and sepsis.
References:

  • Urinary Tract Infection (2)

By Targets:
Show More (9)
By Categories:
By Clinical Status:
Urinary Tract Infection
Clear Filters
Pivalic acid
Pivalic acid
0 Images
Cat. No.: HY-Y1150
CAS No.: 75-98-9
Purity: 99.93%
Synonyms: Trimethylmethanecarboxylic acid; Versatic 5 acid; tert-Pentanoic acid
  • Formula: C5H10O2
  • Molecular Weight: 102.13

Pivalic acid (Trimethylmethanecarboxylic acid) is a carboxylic acid. Pivalic acid induces Carnitine deficiency. Pivalic acid conjugated with Antibiotics, such as Pivmecillinam (HY-B0810) and Pivampicillin (HY-119011), are used in urinary tract infection. Pivalic acid can be used in physical exercise research.

loading...
    loading...
View All Sizes
5-(3',4'-Dihydroxyphenyl)-γ-valerolactone
5-(3',4'-Dihydroxyphenyl)-γ-valerolactone
0 Images
Cat. No.: HY-W509797
CAS No.: 21618-92-8
Purity: 99.16%
  • Formula: C11H12O4
  • Molecular Weight: 208.21

5-(3',4'-Dihydroxyphenyl)-γ-valerolactone is an intestinal microbiota metabolite of (-)-Epicatechin (HY-N0001). 5-(3',4'-Dihydroxyphenyl)-γ-valerolactone downregulates TNF-α-stimulated phosphorylation of IKK and IκBα, inhibits the transcriptional activation of NF-κB, and suppresses the expression of adhesion molecules and chemokines. 5-(3',4'-Dihydroxyphenyl)-γ-valerolactone promotes autophagy, alleviates oxidative stress, maintains osteoblast differentiation, induces G1 phase arrest, inhibits adipogenesis, and scavenges ABTS free radicals. 5-(3',4'-Dihydroxyphenyl)-γ-valerolactone inhibits the adhesion of uropathogenic Escherichia coli to bladder epithelial cells; when used in combination with Curcumin (HY-N0005), it downregulates the NLRP3 and NOX2/Nrf2 signaling pathways, thereby reducing microglial activation. 5-(3',4'-Dihydroxyphenyl)-γ-valerolactone can be used in research related to diabetes, atherosclerosis, osteoporosis, obesity, neurodegenerative diseases involving microglial activation, and urinary tract infections.

loading...
    loading...
View All Sizes
Assay Types